U.S. agrees to pay Sanofi and GSK $2.1 billion for 100 million doses of coronavirus vaccine

The U.S. government will pay Sanofi and GlaxoSmithKline up to $2.1 billion to develop and deliver 100 million doses of their potential coronavirus vaccine. More than half of the $1.5 billion will be used to support further development of the vaccine, including clinical trials, with the remainder used for manufacturing and delivery of the 100 million doses, the companies said. The announcement comes less than two weeks after the government said it would pay Pfizer and BioNTech $1.95 billion to produce 100 million doses of their vaccine.